Lara Lewington

The chance of overdiagnosis, people finding out about things they never needed to know about, all of this is very real.

Yet at the same time, people will be diagnosed and lives will be saved.

So it's quite hard, that balance.

But talking about those scans that are available, and there are numerous different ones that do different types of scans, some being MRIs, some being more surface level.

And I think it's important that if anybody is paying for these scans, that they really understand what they're looking at and what they're not looking at and have absolute clarity on that.

Because having tested so many of these things, I really see what is seen in what scan, what isn't.

And we really need to understand what we're being told and what that means to us.

And this may all sound terribly obvious, but I'm not sure that it is in practice.

And it's very hard to express all of this array of information to people because we don't know what disease we're going to be struck by.

So I look at the future as being so much better because we have all this information, we can understand so much more, but I also think that this is really crucial to be kept safely within the realms of medicine in most cases.

So a lot of what I talk about is

that people want to know what they can do to help themselves.

So I do go into sleep, exercise, food, and the role that technology and AI plays in driving us to do the right thing.

And it's not just a matter of tracking what we do, but we can actually now get the feedback from our bodies to see how we respond to any changes that we make.

And that's quite useful information.

But a huge amount of the stuff I cover in Hacking Humanity is a look at what's happening in healthcare, in research as well,

and what's becoming possible because it's absolutely remarkable where we're going.

And the changes in, I mean, as you've just mentioned, when it comes to cancer, cancer means so many different things.

And it's because of the fact there are so many different variables, the type of the cancer, the location of the cancer, the genetics of the tumor, the genetics and microbiome of the person being treated.

There's so much in it that as we have more data, we'll understand more about kind of treatment and how we can target the tumor harder and hurt the patient less.